Overview
Hereditary sclerosing poikiloderma, Weary type (also known as Weary-Kindler syndrome or hereditary sclerosing poikiloderma) is an extremely rare genodermatosis characterized by a distinctive combination of skin changes that typically begin in early childhood. The condition is classified under the broader group of inherited poikilodermas — disorders featuring mottled skin pigmentation, telangiectasia (small dilated blood vessels), and skin atrophy. The hallmark features include diffuse poikiloderma with areas of hyperpigmentation and hypopigmentation, skin sclerosis (hardening and thickening of the skin), and progressive changes that primarily affect the skin. Patients may develop scleroderma-like changes of the extremities, linear hyperkeratotic and sclerotic bands on the limbs, and widespread reticulated pigmentary changes. The condition can also be associated with palmoplantar keratoderma (thickening of the skin on palms and soles) and may involve the nails. The skin findings tend to be progressive over time. There is currently no curative treatment for hereditary sclerosing poikiloderma, Weary type. Management is supportive and symptomatic, focusing on skin care, sun protection to minimize photosensitivity-related damage, and monitoring for potential complications. Emollients and keratolytic agents may be used to manage hyperkeratotic areas. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, much of the clinical understanding is derived from a limited number of reported families.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Hereditary sclerosing poikiloderma, Weary type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary sclerosing poikiloderma, Weary type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hereditary sclerosing poikiloderma, Weary type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary sclerosing poikiloderma, Weary type.
Community
No community posts yet. Be the first to share your experience with Hereditary sclerosing poikiloderma, Weary type.
Start the conversation →Latest news about Hereditary sclerosing poikiloderma, Weary type
No recent news articles for Hereditary sclerosing poikiloderma, Weary type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary sclerosing poikiloderma, Weary type
What is Hereditary sclerosing poikiloderma, Weary type?
Hereditary sclerosing poikiloderma, Weary type (also known as Weary-Kindler syndrome or hereditary sclerosing poikiloderma) is an extremely rare genodermatosis characterized by a distinctive combination of skin changes that typically begin in early childhood. The condition is classified under the broader group of inherited poikilodermas — disorders featuring mottled skin pigmentation, telangiectasia (small dilated blood vessels), and skin atrophy. The hallmark features include diffuse poikiloderma with areas of hyperpigmentation and hypopigmentation, skin sclerosis (hardening and thickening o
How is Hereditary sclerosing poikiloderma, Weary type inherited?
Hereditary sclerosing poikiloderma, Weary type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hereditary sclerosing poikiloderma, Weary type typically begin?
Typical onset of Hereditary sclerosing poikiloderma, Weary type is childhood. Age of onset can vary across affected individuals.